Aroylated phenylenediamine HO53 modulates innate immunity, histone acetylation and metabolism

• Published in: Molecular immunology Vol. 155; pp. 153 - 164
• Main Authors: Barrier, Marjorie Laurence, Myszor, Iwona Teresa, Sahariah, Priyanka, Sigurdsson, Snaevar, Carmena-Bargueño, Miguel, Pérez-Sánchez, Horacio, Gudmundsson, Gudmundur Hrafn
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-03-2023
• Subjects: Acetylation; Aroylated Phenylenediamine; Cathelicidins; HDAC3; Histone Deacetylase Inhibitors - pharmacology; Histones - metabolism; Immunity, Innate; Immunometabolism; Innate Immunity; Phenylenediamines - pharmacology; Ac; BD; HDAC3; Innate Immunity; BCi; NFATc2; OGDHL; SLC2A4; PBA; PDH; mTOR; PDK4; Acetylation; HIF1α; CAMP; PDK2; CPA4; STRA6; GCKR; AMP; AULK1; PGAM2; STAT3; H3; RNAseq; SCFA; Aroylated Phenylenediamine; Immunometabolism; IL6; TCA; APD; LCN2; HAT; SEM; ALDOB; log2FC; ALI; PFKP; COPD; HDAC
• ISSN: 0161-5890; 1872-9142
• DOI: 10.1016/j.molimm.2023.02.003

In the current context of antibiotic resistance, the need to find alternative treatment strategies is urgent. Our research aimed to use synthetized aroylated phenylenediamines (APDs) to induce the expression of cathelicidin antimicrobial peptide gene (CAMP) to minimize the necessity of antibiotic use during infection. One of these compounds, HO53, showed promising results in inducing CAMP expression in bronchial epithelium cells (BCi-NS1.1 hereafter BCi). Thus, to decipher the cellular effects of HO53 on BCi cells, we performed RNA sequencing (RNAseq) analysis after 4, 8 and 24 h treatment of HO53. The number of differentially expressed transcripts pointed out an epigenetic modulation. Yet, the chemical structure and in silico modeling indicated HO53 as a histone deacetylase (HDAC) inhibitor. When exposed to a histone acetyl transferase (HAT) inhibitor, BCi cells showed a decreased expression of CAMP. Inversely, when treated with a specific HDAC3 inhibitor (RGFP996), BCi cells showed an increased expression of CAMP, indicating acetylation status in cells as determinant for the induction of the expression of the gene CAMP expression. Interestingly, a combination treatment with both HO53 and HDAC3 inhibitor RGFP966 leads to a further increase of CAMP expression. Moreover, HDAC3 inhibition by RGFP966 leads to increased expression of STAT3 and HIF1A, both previously demonstrated to be involved in pathways regulating CAMP expression. Importantly, HIF1α is considered as a master regulator in metabolism. A significant number of genes of metabolic enzymes were detected in our RNAseq data with enhanced expression conveying a shift toward enhanced glycolysis. Overall, we are demonstrating that HO53 might have a translational value against infections in the future through a mechanism leading to innate immunity strengthening involving HDAC inhibition and shifting the cells towards an immunometabolism, which further favors innate immunity activation.
[Display omitted]
•Antimicrobial inducer Aroylated Phenylenediamine HO53 also acts as HDAC inhibitor.•Specific HDAC3 inhibition further enhances HO53-induced CAMP expression.•HO53 increases expression of CAMP and metabolic genes, altering immunometabolism.•HO53 affects HDAC3/STAT3/HIF1α/CAMP pathway.